According to the research report published by Market IntelliX, the global market for Phosphodiesterase-5 Inhibitor should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Phosphodiesterase-5 Inhibitor market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Phosphodiesterase-5 Inhibitor market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

By segment, Hospital grew percent to account for percent of the total market sales, and Pharmaceutical Company grew percent.

This report studies and analyses global Phosphodiesterase-5 Inhibitor status and future trends, helps the client to determine the Phosphodiesterase-5 Inhibitor market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Phosphodiesterase-5 Inhibitor, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights

(1) Global Phosphodiesterase-5 Inhibitor market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)

(2) Global Phosphodiesterase-5 Inhibitor sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(3) China Phosphodiesterase-5 Inhibitor sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(4) Global Phosphodiesterase-5 Inhibitor key consuming regions, consumption quantity, consumption value and demand structure

(5) Global Phosphodiesterase-5 Inhibitor key producing regions, capacity, production, and year over year growth

(6) Phosphodiesterase-5 Inhibitor industry chains, upstream, midstream and downstream

Market segment by players, this report covers

Pfizer

Eli Lilly

Baye

Dong-A Pharm

Torrent Pharmaceuticals

GSK

Abbott Laboratories

Teva Pharmaceuticals

Hetero Drugs

Zydus Cadila

Market segment by Type, covers

Oral Tablet

Oral Liquid

Market segment by Application, can be divided into

Hospital

Pharmaceutical Company

Laboratory

Clinic

Others

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Report Includes:

Chapter 1: to describe Phosphodiesterase-5 Inhibitor product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Phosphodiesterase-5 Inhibitor market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 3: China Phosphodiesterase-5 Inhibitor market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 4: Global key producing regions of Phosphodiesterase-5 Inhibitor, percent & CAGR, 2018-2029

Chapter 5: Phosphodiesterase-5 Inhibitor industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Phosphodiesterase-5 Inhibitor Definition

1.2 Global Phosphodiesterase-5 Inhibitor Market Size and Forecast

1.2.1 By Consumption Value, Global Phosphodiesterase-5 Inhibitor Market Size，2018-2029

1.2.2 By Sales Quantity, Global Phosphodiesterase-5 Inhibitor Market Size，2018-2029

1.2.3 Global Phosphodiesterase-5 Inhibitor Average Selling Price (ASP)，2018-2029

1.3 China Phosphodiesterase-5 Inhibitor Market Size and Forecast

1.3.1 By Consumption Value, China Phosphodiesterase-5 Inhibitor Market Size，2018-2029

1.3.2 By Sales Quantity, China Phosphodiesterase-5 Inhibitor Market Size，2018-2029

1.3.3 China Phosphodiesterase-5 Inhibitor Average Selling Price (ASP)， 2018-2029

1.4 Share of China Phosphodiesterase-5 Inhibitor Market with Respect to the Global Market

1.4.1 By Consumption Value, China Phosphodiesterase-5 Inhibitor Market Share in Global, 2018-2029

1.4.2 By Sales Quantity, China Phosphodiesterase-5 Inhibitor Market Share in Global, 2018-2029

1.4.3 Phosphodiesterase-5 Inhibitor Market Size: China VS Global, 2018-2029

1.5 Phosphodiesterase-5 Inhibitor Market Dynamics

1.5.1 Phosphodiesterase-5 Inhibitor Market Drivers

1.5.2 Phosphodiesterase-5 Inhibitor Market Restraints

1.5.3 Phosphodiesterase-5 Inhibitor Industry Trends

1.5.4 Phosphodiesterase-5 Inhibitor Industry Policy

2 Global Leading Manufacturers and Market Share

2.1 By Revenue of Phosphodiesterase-5 Inhibitor, Global Market Share by Company, 2018-2023

2.2 By Sales Quantity of Phosphodiesterase-5 Inhibitor, Global Market Share by Company, 2018-2023

2.3 Phosphodiesterase-5 Inhibitor Average Selling Price (ASP) by Company, 2018-2023

2.4 Global Phosphodiesterase-5 Inhibitor Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.5 Global Phosphodiesterase-5 Inhibitor Concentration Ratio

2.6 Global Phosphodiesterase-5 Inhibitor Mergers & Acquisitions, Expansion Plans

2.7 Global Phosphodiesterase-5 Inhibitor Manufacturers Product Type

2.8 Head Office and Phosphodiesterase-5 Inhibitor Production Site of Key Manufacturer

2.9 Phosphodiesterase-5 Inhibitor Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share

3.1 By Revenue of Phosphodiesterase-5 Inhibitor, China Market Share by Company, 2018-2023

3.2 By Sales Quantity of Phosphodiesterase-5 Inhibitor, China Market Share by Company, 2018-2023

3.3 China Phosphodiesterase-5 Inhibitor Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions

4.1 Global Phosphodiesterase-5 Inhibitor Capacity, Output and Capacity Utilization, 2018-2029

4.2 Global Phosphodiesterase-5 Inhibitor Capacity by Region

4.3 Global Phosphodiesterase-5 Inhibitor Production & Forecast by Region, 2018 VS 2022 VS 2029

4.4 Global Phosphodiesterase-5 Inhibitor Production by Region, 2018-2029

4.5 Global Phosphodiesterase-5 Inhibitor Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Phosphodiesterase-5 Inhibitor Industry Chain

5.2 Phosphodiesterase-5 Inhibitor Upstream Analysis

5.2.1 Phosphodiesterase-5 Inhibitor Core Raw Materials

5.2.2 Main Manufacturers of Phosphodiesterase-5 Inhibitor Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Phosphodiesterase-5 Inhibitor Production Mode

5.6 Phosphodiesterase-5 Inhibitor Procurement Model

5.7 Phosphodiesterase-5 Inhibitor Industry Sales Model and Sales Channels

5.7.1 Phosphodiesterase-5 Inhibitor Sales Model

5.7.2 Phosphodiesterase-5 Inhibitor Typical Distributors

6 Sights by Type

6.1 Phosphodiesterase-5 Inhibitor Classification

6.1.1 Oral Tablet

6.1.2 Oral Liquid

6.2 By Type, Global Phosphodiesterase-5 Inhibitor Consumption Value & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Phosphodiesterase-5 Inhibitor Consumption Value, 2018-2029

6.4 By Type, Global Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029

6.5 By Type, Global Phosphodiesterase-5 Inhibitor Average Selling Price (ASP), 2018-2029

7 Sights by Application

7.1 Phosphodiesterase-5 Inhibitor Segment by Application

7.1.1 Hospital

7.1.2 Pharmaceutical Company

7.1.3 Laboratory

7.1.4 Clinic

7.1.5 Others

7.2 By Application, Global Phosphodiesterase-5 Inhibitor Consumption Value & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Phosphodiesterase-5 Inhibitor Consumption Value, 2018-2029

7.4 By Application, Global Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029

7.5 By Application, Global Phosphodiesterase-5 Inhibitor Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Phosphodiesterase-5 Inhibitor Consumption Value, 2018 VS 2022 VS 2029

8.2 By Region, Global Phosphodiesterase-5 Inhibitor Consumption Value, 2018-2029

8.3 By Region, Global Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029

8.4 North America

8.4.1 North America Phosphodiesterase-5 Inhibitor & Forecasts, 2018-2029

8.4.2 By Country, North America Phosphodiesterase-5 Inhibitor Market Size Market Share

8.5 Europe

8.5.1 Europe Phosphodiesterase-5 Inhibitor Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Phosphodiesterase-5 Inhibitor Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Phosphodiesterase-5 Inhibitor Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Phosphodiesterase-5 Inhibitor Market Size Market Share

8.7 South America

8.7.1 South America Phosphodiesterase-5 Inhibitor Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Phosphodiesterase-5 Inhibitor Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Phosphodiesterase-5 Inhibitor Market Size & CAGR, 2018 VS 2022 VS 2029

9.2 By Country, Global Phosphodiesterase-5 Inhibitor Consumption Value, 2018-2029

9.3 By Country, Global Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029

9.4 U.S.

9.4.1 U.S. Phosphodiesterase-5 Inhibitor Market Size, 2018-2029

9.4.2 By Type, U.S. Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.4.3 By Application, U.S. Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Phosphodiesterase-5 Inhibitor Market Size, 2018-2029

9.5.2 By Type, Europe Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.5.3 By Application, Europe Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.6 China

9.6.1 China Phosphodiesterase-5 Inhibitor Market Size, 2018-2029

9.6.2 By Type, China Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.6.3 By Application, China Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Phosphodiesterase-5 Inhibitor Market Size, 2018-2029

9.7.2 By Type, Japan Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.7.3 By Application, Japan Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Phosphodiesterase-5 Inhibitor Market Size, 2018-2029

9.8.2 By Type, South Korea Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.8.3 By Application, South Korea Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Phosphodiesterase-5 Inhibitor Market Size, 2018-2029

9.9.2 By Type, Southeast Asia Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.9.3 By Application, Southeast Asia Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.10 India

9.10.1 India Phosphodiesterase-5 Inhibitor Market Size, 2018-2029

9.10.2 By Type, India Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.10.3 By Application, India Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.11 Middle East & Africa

9.11.1 Middle East & Africa Phosphodiesterase-5 Inhibitor Market Size, 2018-2029

9.11.2 By Type, Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

9.11.3 By Application, Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Pfizer

10.1.1 Pfizer Company Information, Head Office, Market Area, and Industry Position

10.1.2 Pfizer Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

10.1.3 Pfizer Phosphodiesterase-5 Inhibitor Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Pfizer Company Profile and Main Business

10.1.5 Pfizer Recent Developments

10.2 Eli Lilly

10.2.1 Eli Lilly Company Information, Head Office, Market Area, and Industry Position

10.2.2 Eli Lilly Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

10.2.3 Eli Lilly Phosphodiesterase-5 Inhibitor Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Eli Lilly Company Profile and Main Business

10.2.5 Eli Lilly Recent Developments

10.3 Baye

10.3.1 Baye Company Information, Head Office, Market Area, and Industry Position

10.3.2 Baye Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

10.3.3 Baye Phosphodiesterase-5 Inhibitor Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Baye Company Profile and Main Business

10.3.5 Baye Recent Developments

10.4 Dong-A Pharm

10.4.1 Dong-A Pharm Company Information, Head Office, Market Area, and Industry Position

10.4.2 Dong-A Pharm Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

10.4.3 Dong-A Pharm Phosphodiesterase-5 Inhibitor Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Dong-A Pharm Company Profile and Main Business

10.4.5 Dong-A Pharm Recent Developments

10.5 Torrent Pharmaceuticals

10.5.1 Torrent Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

10.5.2 Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

10.5.3 Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Torrent Pharmaceuticals Company Profile and Main Business

10.5.5 Torrent Pharmaceuticals Recent Developments

10.6 GSK

10.6.1 GSK Company Information, Head Office, Market Area, and Industry Position

10.6.2 GSK Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

10.6.3 GSK Phosphodiesterase-5 Inhibitor Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.6.4 GSK Company Profile and Main Business

10.6.5 GSK Recent Developments

10.7 Abbott Laboratories

10.7.1 Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position

10.7.2 Abbott Laboratories Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

10.7.3 Abbott Laboratories Phosphodiesterase-5 Inhibitor Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Abbott Laboratories Company Profile and Main Business

10.7.5 Abbott Laboratories Recent Developments

10.8 Teva Pharmaceuticals

10.8.1 Teva Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

10.8.2 Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

10.8.3 Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Teva Pharmaceuticals Company Profile and Main Business

10.8.5 Teva Pharmaceuticals Recent Developments

10.9 Hetero Drugs

10.9.1 Hetero Drugs Company Information, Head Office, Market Area, and Industry Position

10.9.2 Hetero Drugs Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

10.9.3 Hetero Drugs Phosphodiesterase-5 Inhibitor Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Hetero Drugs Company Profile and Main Business

10.9.5 Hetero Drugs Recent Developments

10.10 Zydus Cadila

10.10.1 Zydus Cadila Company Information, Head Office, Market Area, and Industry Position

10.10.2 Zydus Cadila Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

10.10.3 Zydus Cadila Phosphodiesterase-5 Inhibitor Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Zydus Cadila Company Profile and Main Business

10.10.5 Zydus Cadila Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Phosphodiesterase-5 Inhibitor Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Phosphodiesterase-5 Inhibitor Market Restraints

Table 3. Phosphodiesterase-5 Inhibitor Market Trends

Table 4. Phosphodiesterase-5 Inhibitor Industry Policy

Table 5. Global Phosphodiesterase-5 Inhibitor Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Phosphodiesterase-5 Inhibitor Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Phosphodiesterase-5 Inhibitor Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Phosphodiesterase-5 Inhibitor Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global Phosphodiesterase-5 Inhibitor Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)

Table 10. Global Phosphodiesterase-5 Inhibitor Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Phosphodiesterase-5 Inhibitor Mergers & Acquisitions, Expansion Plans

Table 12. Global Phosphodiesterase-5 Inhibitor Manufacturers Product Type

Table 13. Head Office and Phosphodiesterase-5 Inhibitor Production Site of Key Manufacturer

Table 14. Phosphodiesterase-5 Inhibitor Capacity of Major Manufacturers and Future Plan

Table 15. China Phosphodiesterase-5 Inhibitor Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China Phosphodiesterase-5 Inhibitor Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 17. China Phosphodiesterase-5 Inhibitor Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global Phosphodiesterase-5 Inhibitor Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 19. Global Phosphodiesterase-5 Inhibitor Production by Region, 2018-2023, (K Units)

Table 20. Global Phosphodiesterase-5 Inhibitor Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Phosphodiesterase-5 Inhibitor Upstream (Raw Materials)

Table 22. Global Phosphodiesterase-5 Inhibitor Typical Customers

Table 23. Phosphodiesterase-5 Inhibitor Typical Distributors

Table 24. By Type, Global Phosphodiesterase-5 Inhibitor Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global Phosphodiesterase-5 Inhibitor Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global Phosphodiesterase-5 Inhibitor Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global Phosphodiesterase-5 Inhibitor Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029, (K Units)

Table 29. By Country, Global Phosphodiesterase-5 Inhibitor Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global Phosphodiesterase-5 Inhibitor Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global Phosphodiesterase-5 Inhibitor Consumption Value Market Share, 2018-2029

Table 32. By Country, Global Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029, (K Units)

Table 33. By Country, Global Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2018-2029

Table 34. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 35. Pfizer Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

Table 36. Pfizer Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 37. Pfizer Company Profile and Main Business

Table 38. Pfizer Recent Developments

Table 39. Eli Lilly Company Information, Head Office, Market Area, and Industry Position

Table 40. Eli Lilly Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

Table 41. Eli Lilly Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Eli Lilly Company Profile and Main Business

Table 43. Eli Lilly Recent Developments

Table 44. Baye Company Information, Head Office, Market Area, and Industry Position

Table 45. Baye Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

Table 46. Baye Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Baye Company Profile and Main Business

Table 48. Baye Recent Developments

Table 49. Dong-A Pharm Company Information, Head Office, Market Area, and Industry Position

Table 50. Dong-A Pharm Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

Table 51. Dong-A Pharm Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Dong-A Pharm Company Profile and Main Business

Table 53. Dong-A Pharm Recent Developments

Table 54. Torrent Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 55. Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

Table 56. Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Torrent Pharmaceuticals Company Profile and Main Business

Table 58. Torrent Pharmaceuticals Recent Developments

Table 59. GSK Company Information, Head Office, Market Area, and Industry Position

Table 60. GSK Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

Table 61. GSK Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. GSK Company Profile and Main Business

Table 63. GSK Recent Developments

Table 64. Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position

Table 65. Abbott Laboratories Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

Table 66. Abbott Laboratories Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Abbott Laboratories Company Profile and Main Business

Table 68. Abbott Laboratories Recent Developments

Table 69. Teva Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 70. Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

Table 71. Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Teva Pharmaceuticals Company Profile and Main Business

Table 73. Teva Pharmaceuticals Recent Developments

Table 74. Hetero Drugs Company Information, Head Office, Market Area, and Industry Position

Table 75. Hetero Drugs Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

Table 76. Hetero Drugs Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Hetero Drugs Company Profile and Main Business

Table 78. Hetero Drugs Recent Developments

Table 79. Zydus Cadila Company Information, Head Office, Market Area, and Industry Position

Table 80. Zydus Cadila Phosphodiesterase-5 Inhibitor Models, Specifications, and Application

Table 81. Zydus Cadila Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Zydus Cadila Company Profile and Main Business

Table 83. Zydus Cadila Recent Developments

List of Figures

Figure 1. Phosphodiesterase-5 Inhibitor Picture

Figure 2. Global Phosphodiesterase-5 Inhibitor Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global Phosphodiesterase-5 Inhibitor Sales Quantity, (K Units) & (2018-2029)

Figure 4. Global Phosphodiesterase-5 Inhibitor Average Selling Price (ASP), (2018-2029) & (US$/Unit)

Figure 5. China Phosphodiesterase-5 Inhibitor Consumption Value, (US$ million) & (2018-2029)

Figure 6. China Phosphodiesterase-5 Inhibitor Sales Quantity (K Units) & (2018-2029)

Figure 7. China Phosphodiesterase-5 Inhibitor Average Selling Price (ASP), (US$/Unit) & (2018-2029)

Figure 8. By Consumption Value, China Phosphodiesterase-5 Inhibitor Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China Phosphodiesterase-5 Inhibitor Market Share of Global, 2018-2029

Figure 10. Global Phosphodiesterase-5 Inhibitor Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Phosphodiesterase-5 Inhibitor Key Participants, Market Share, 2022

Figure 12. Global Phosphodiesterase-5 Inhibitor Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global Phosphodiesterase-5 Inhibitor Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Phosphodiesterase-5 Inhibitor Production Market Share & Forecast by Region, 2018-2029

Figure 15. Phosphodiesterase-5 Inhibitor Industry Chain

Figure 16. Phosphodiesterase-5 Inhibitor Procurement Model

Figure 17. Phosphodiesterase-5 Inhibitor Sales Model

Figure 18. Phosphodiesterase-5 Inhibitor Sales Channels, Direct Sales, and Distribution

Figure 19. Oral Tablet

Figure 20. Oral Liquid

Figure 21. By Type, Global Phosphodiesterase-5 Inhibitor Consumption Value, 2018-2029, US$ Million

Figure 22. By Type, Global Phosphodiesterase-5 Inhibitor Consumption Value Market Share, 2018-2029

Figure 23. By Type, Global Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029, (K Units)

Figure 24. By Type, Global Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2018-2029

Figure 25. By Type, Global Phosphodiesterase-5 Inhibitor Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 26. Hospital

Figure 27. Pharmaceutical Company

Figure 28. Laboratory

Figure 29. Clinic

Figure 30. Others

Figure 31. By Application, Global Phosphodiesterase-5 Inhibitor Consumption Value, 2018-2029, US$ Million

Figure 32. By Application, Global Phosphodiesterase-5 Inhibitor Consumption Value Market Share, 2018-2029

Figure 33. By Application, Global Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029, (K Units)

Figure 34. By Application, Global Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2018-2029

Figure 35. By Application, Global Phosphodiesterase-5 Inhibitor Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 36. By Region, Global Phosphodiesterase-5 Inhibitor Consumption Value Market Share, 2018-2029

Figure 37. By Region, Global Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2018-2029

Figure 38. North America Phosphodiesterase-5 Inhibitor Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 39. By Country, North America Phosphodiesterase-5 Inhibitor Consumption Value Market Share, 2022

Figure 40. Europe Phosphodiesterase-5 Inhibitor Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 41. By Country, Europe Phosphodiesterase-5 Inhibitor Consumption Value Market Share, 2022

Figure 42. Asia Pacific Phosphodiesterase-5 Inhibitor Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 43. By Country/Region, Asia Pacific Phosphodiesterase-5 Inhibitor Consumption Value Market Share, 2022

Figure 44. South America Phosphodiesterase-5 Inhibitor Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 45. By Country, South America Phosphodiesterase-5 Inhibitor Consumption Value Market Share, 2022

Figure 46. Middle East & Africa Phosphodiesterase-5 Inhibitor Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 47. U.S. Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029, (K Units)

Figure 48. By Type, U.S. Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 49. By Application, U.S. Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 50. Europe Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029, (K Units)

Figure 51. By Type, Europe Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 52. By Application, Europe Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 53. China Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029, (K Units)

Figure 54. By Type, China Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 55. By Application, China Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 56. Japan Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029, (K Units)

Figure 57. By Type, Japan Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 58. By Application, Japan Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 59. South Korea Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029, (K Units)

Figure 60. By Type, South Korea Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 61. By Application, South Korea Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 62. Southeast Asia Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029, (K Units)

Figure 63. By Type, Southeast Asia Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 64. By Application, Southeast Asia Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 65. India Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029, (K Units)

Figure 66. By Type, India Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 67. By Application, India Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 68. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity, 2018-2029, (K Units)

Figure 69. By Type, Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 70. By Application, Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity Market Share, 2022 VS 2029

Figure 71. Research Methodology

Figure 72. Breakdown of Primary Interviews

Figure 73. Bottom-up and Top-down Approaches

Figure 74. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)